Filing Details
- Accession Number:
- 0001209191-19-050709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-25 16:32:03
- Reporting Period:
- 2019-09-10
- Accepted Time:
- 2019-09-25 16:32:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401667 | Puma Biotechnology Inc. | PBYI | Pharmaceutical Preparations (2834) | 770683487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1727172 | M Douglas Hunt | C/O Puma Biotechnology, Inc. 10880 Wilshire Boulevard, Suite 2150 Los Angeles CA 90024 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-10 | 4,500 | $0.00 | 14,400 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-09-12 | 1,711 | $11.42 | 12,689 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares issued pursuant to performance based vesting of restricted stock units.
- The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.